Navigation Links
U.S. Pharmacopeia Releases New Edition of the Food Chemicals Codex
Date:3/4/2008

Internationally Recognized Compendium Helps to Assure the Safety and Purity

of Food Ingredients

ROCKVILLE, Md., March 4 /PRNewswire/ -- The U.S. Pharmacopeia (USP) today announced the release of the latest edition of the Food Chemicals Codex (FCC), a compendium that sets standards for the identity, quality and purity of ingredients found in foods consumed by the public every day, including colorings, flavorings, nutrients, preservatives and processing aids.

The new edition is the sixth publication of the compendium since 1966, and the first under USP's direction, having previously been published by the Institute of Medicine. The compendium is used by manufacturers of food, food chemicals and food ingredients to ensure that their products meet identity, purity and quality standards. As a private, science-based, non-governmental organization that sets the standards that prescription and over-the-counter medications sold in the United States must meet by law via the United States Pharmacopeia-National Formulary (USP-NF) compendia, USP is well qualified to set similar standards for food ingredients.

"With the increasing globalization of the food supply, the availability of pure and safe foods is more important than ever," said Darrell Abernethy, M.D., Ph.D., chief science officer for USP. "This latest edition of the Food Chemicals Codex will help assure that food ingredients are meeting high standards of quality for public consumption, just as USP has done with pharmaceutical products for close to 200 years."

The new edition contains more than 1,000 monograph standards and tests to assure the identity, quality and purity of food ingredients. A new edition will be published every two years, with an annual supplement between editions. The FCC will be revised and updated via an open, transparent, participatory and scientific process that includes experts from industry as well as scientific, technical, governmental and trade organizations. All interested parties are encouraged to submit proposed revisions and comments through the online FCC Forum (http://www.usp.org/fcc/forum), the mechanism through which USP revises FCC standards by a process of public review and comment. The process is similar to the one USP relies on to establish federally recognized drug standards in the USP-NF.

For more information or to purchase the FCC, please visit http://www.usp.org/fcc. For media inquiries, please contact mediarelations@usp.org.

USP -- Advancing Public Health Since 1820

The United States Pharmacopeia (USP) is a private, non-profit, standards-setting organization that advances public health by ensuring the quality and consistency of medicines, promoting the safe and proper use of medications, and verifying ingredients in dietary supplements. These standards, which are recognized worldwide, are developed by a unique process of public involvement through the contributions of volunteers representing pharmacy, medicine, and other health care professions, as well as science, academia, government, the pharmaceutical industry, and consumer organizations. For more information about USP and its four public health programs, visit http://www.usp.org/newscenter.


'/>"/>
SOURCE U.S. Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. US Pharmacopeia releases new edition of the Food Chemicals Codex
2. Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
3. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
4. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
5. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
6. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
7. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
8. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
9. Pharmacopeia Announces Senior Additions to Management Team
10. NIDDK releases new awareness and prevention series for community health events
11. Skin Friendly Releases Clinically Proven Hypoallergenic Anti-Bacterial Barrier Lotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2017)... (PRWEB) , ... April 23, 2017 , ... ... and managed services announced the achievement of Cisco Select certification and SMB specialization. ... the United States. , In earning the Select Certification, Altura fulfilled ...
(Date:4/22/2017)... , ... April 22, 2017 , ... The San Juan Capistrano summer camp ... parenting report outlining the need for summer camps to provide physical activities for all campers. ... Physical Activity In Summer Camps , With an increase in specialty camps that focus on ...
(Date:4/21/2017)... ... , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has ... bony lump located on the forehead usually attributed to a facial fracture. Their appearance ... Dr. Shah has discovered an approach that is minimally invasive. He is an expert ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies ... project in the company’s esteemed VISION House demonstration project series. Manifesting the concept of ... of resources they need to live affordably and abundantly without unduly taxing the resources ...
(Date:4/21/2017)... Sterling, VA (PRWEB) , ... April 21, 2017 ... ... hosting its first weeklong campaign, AWARE: A Week of Addiction and Recovery Education, ... emerging evidence in treating and preventing substance use disorders. , The mission ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology: